Biotech · Private company · Clifton Park, NY, US
iPACES LLC
Track this companyFree. Adds iPACES LLC to your Dealase workspace and tells you when its record changes.
Clinical trials20 recruiting or active
Pipeline programs4From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline4
- iPACES (interactive Physical and Cognitive Exercise System)MCIClinicalTrials.gov · fetched Nov 12, 2026
- iPACES (interactive Physical and Cognitive Exercise System)Parkinson's DiseaseClinicalTrials.gov · fetched Nov 12, 2026
- PACE (Physical and Cognitive Exercise)MCIClinicalTrials.gov · fetched Nov 12, 2026
- PACE (Physical and Cognitive Exercise)Parkinson's DiseaseClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials2
- iPACES v3 MCI NIA Protocol Copied for iPACES v4 PD NINDSNA · UNKNOWN · started Aug 1, 2023ClinicalTrials.gov NCT05810454 · fetched Nov 12, 2026
- The Interactive Physical and Cognitive Exercise System (v3) for Mild Cognitive Impairment (MCI)NA · UNKNOWN · started Aug 23, 2021ClinicalTrials.gov NCT05009524 · fetched Nov 12, 2026
NIH awards3
- Neuro-exergaming for the Prevention and Remediation of Decline due to Parkinson's Disease: Clinical Trial of the Interactive Physical and Cognitive Exercise System (iPACES v3)Fiscal year 2026 · $50KNIH RePORTER 3R44NS132690-03S1 · fetched Nov 12, 2026
- Neuro-exergaming for the Prevention and Remediation of Decline due to Parkinson's Disease: Clinical Trial of the Interactive Physical and Cognitive Exercise System (iPACES v3)Fiscal year 2025 · $1.4MNIH RePORTER 5R44NS132690-03 · fetched Nov 12, 2026
- Neuro-exergaming for the Prevention and Remediation of Decline due to Parkinson's Disease: Clinical Trial of the Interactive Physical and Cognitive Exercise System (iPACES v3)Fiscal year 2024 · $1.4MNIH RePORTER 5R44NS132690-02 · fetched Nov 12, 2026